Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
ACORDA THERAPEUTICS Add to My Watchlist (NSDQ: ACOR) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Acorda 29.99 +0.07 (+0.23%) 954,133
15 Skyline Drive
Hawthorne, NY 10532 US
(914) 347-4300
(914) 347-4560 fax
www.acorda.com
CEO Ron Cohen, M.D.
Auditor KPMG LLP
Exchange Traded NQ
ISIN Number US00484M1062
CIK Number 1008848
NAICS Code 325414
Business Summary
A biopharmaceutical company, which is engaged in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and disorders of the central nervous sy
Number of Employees 174
Share Fundamentals
Market Cap 1.14B
Shares Outstanding 38.12M
Float 37.43M
Short Interest 3.36M
Financial Strength
Revenue (TTM) $52,694,777
Earnings (TTM) -$81,698,281
Quick Ratio 4.6:1
Current Ratio 4.8:1
Total Debt/Equity 0.05:1
Profitability
Gross Margin 90.0%
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs